Mitochondrial transcription factor A regulates BCL2L1 gene expression and is a prognostic factor in serous ovarian cancer
Article first published online: 23 DEC 2011
© 2011 Japanese Cancer Association
Volume 103, Issue 2, pages 239–444, February 2012
How to Cite
Kurita, T., Izumi, H., Kagami, S., Kawagoe, T., Toki, N., Matsuura, Y., Hachisuga, T. and Kohno, K. (2012), Mitochondrial transcription factor A regulates BCL2L1 gene expression and is a prognostic factor in serous ovarian cancer. Cancer Science, 103: 239–444. doi: 10.1111/j.1349-7006.2011.02156.x
- Issue published online: 1 FEB 2012
- Article first published online: 23 DEC 2011
- Accepted manuscript online: 20 NOV 2011 09:10PM EST
- (Received August 29, 2011/Revised November 11, 2011/Accepted November 14, 2011/Accepted manuscript online November 20, 2011)
Fig. S1. Typical results of immunohistochemical staining of mtTFA and Bcl2L1.
Fig. S2. Comparison of the overall survival rates in 60 patients with serous ovarian cancer according to Bcl2L1 expression.
|CAS_2156_sm_fS1.TIF||2519K||Supporting info item|
|CAS_2156_sm_fS2.TIF||1090K||Supporting info item|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.